Actavis Inc. (ACT)

Actavis Plc (ACT), Illumina Inc (LMN) and Cheniere Energy Inc (LNG) Among Billionaire Halvorsen’s Top Stock Picks

Viking Global Investors is a hedge fund working with pooled investment vehicles on a global level. The company was founded in 1999 by Andreas Halvorsen......(read more)

May 20 - Hedge Funds, News - Comments

Is Salix Pharmaceuticals, Ltd. (SLXP) Going to Burn These Hedge Funds?

Is Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) going to burn you? In the 21st century investor’s toolkit, there are dozens of methods shareholders can......(read more)

August 27 - News - Comments

Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks

We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors. Our research has shown that this information......(read more)

August 27 - Hedge Funds - Comments

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Amgen, Inc. (AMGN): Is Galena Biopharma Inc (GALE)’s Big Break Just Around the Corner?

Judging by the numbers, Galena Biopharma Inc (NASDAQ:GALE) isn’t exactly a stock many would call great. Sure, shares are up more than 45% year-......(read more)

August 26 - News - Comments

Do Hedge Funds and Insiders Love Mylan Inc. (MYL)?

Is Mylan Inc. (NASDAQ:MYL) a buy? To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time. Although......(read more)

August 25 - News - Comments

Elan Corporation, plc (ADR) (ELN), Actavis Inc (ACT): Billionaire James Dinan Liked Pharmaceuticals Last Quarter

Several weeks after the end of each quarter, hedge funds and other major investors are required to file 13Fs with the SEC to disclose many of their long......(read more)

August 19 - Hedge Funds - Comments

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Perrigo Company (PRGO): Obamacare and Generic Pharmaceuticals

Will generic pharmaceutical makers like Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Perrigo Company (NYSE:PRGO) continue to be a value......(read more)

August 12 - News - Comments

Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): This Deal Could Shake Up the Generic Drug Business

Many market-watchers are scratching their heads about the pharmaceutical industry’s latest blockbuster deal. Although it had been expected to make......(read more)

August 12 - News - Comments

Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): Is This Acquisition a Game Changer?

A patented drug is a cash cow for drug manufacturers. There are two ways to have a patented cash generating drug on a pharmaceutical company’s pipeline......(read more)

August 5 - News - Comments

Taro Pharmaceutical Industries Ltd. (TARO), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Conquer the Generic Drug Market With Taro

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) hardly gets the attention it deserves. The Israel-based generic-pharmaceutical manufacturer supplies in......(read more)

August 1 - News - Comments

AstraZeneca plc (ADR) (AZN), Actavis Inc (ACT): Can Fish Oil Help This Drug Giant Regain its Mojo?

AstraZeneca plc (ADR) (NYSE:AZN)’s financial results have been on a downward spiral lately, as patent expirations have led to sharp declines in sales......(read more)

July 15 - News - Comments

The Cheesecake Factory Incorporated (NASDAQ:CAKE)

The Cheesecake Factory Incorporated (CAKE), Actavis Inc (ACT): Turing the “Risk-On” Switch Off

Today’s investing environment is one that forces decisions to be made and, consequently, many errors. In so many cases, investors take an emotional......(read more)

July 10 - News - Comments

AbbVie Inc (ABBV), Amgen, Inc. (AMGN): Do Generic Drugs Drastically Alter Market Dynamics?

Pharma companies have been paying off generic drug makers so that cheap generic drugs do not enter the market. In a settlement case involving AbbVie Inc......(read more)

July 9 - News - Comments

Value Investor Francis Chou’s Top Picks Include…Berkshire Hathaway Inc. (BRK.B)

Francis Chou, of Chou Associates Management, was recognized by Morningstar with the Fund Manager of the Decade award in 2004. We track his quarterly 13F......(read more)

July 9 - Hedge Funds - Comments

Warner Chilcott Plc (WCRX) & Actavis Inc (ACT): Can You Profit From This Pharma Tie-Up

Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August......(read more)

June 27 - News - Comments

Abbott Laboratories (ABT), Merck & Co., Inc. (MRK): The Proprietary Drug Business Just Got Riskier

A new Supreme Court ruling presents pharmaceutical companies with a tough choice — stop paying generic-drug producers to withhold generic options......(read more)

June 20 - News - Comments

Actavis Inc (ACT), AbbVie Inc (ABBV): “Pay-For Delay” Was Fun While It Lasted

When the FTC and the U.S. Supreme Court start breathing down your neck it’s not a pleasant thing, and could become very expensive for certain companies......(read more)

June 18 - News - Comments

Hospira, Inc. (HSP), Mylan Inc. (MYL), Actavis Inc (ACT): Is This Hurting Healthcare Company Priced for a Recovery?

Nothing interests a value investor more than bad news. Where there’s a lack of enthusiasm, there’s usually a cheap stock. Hospira, Inc. (......(read more)

June 14 - News - Comments

Why The Pfizer Inc. (PFE)-Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Settlement Affects the Whole Industy

Generic-drug makers are always on the hunt for the next branded drug to take down. But they can’t just go about launching copycats of every drug......(read more)

June 13 - News - Comments

Warner Chilcott Plc (WCRX): Should You Buy Joel Greenblatt’s Latest Pick?

Searching for potential stock investments can be a daunting task. With so many stocks to choose from – more than 2,300 listed on the NYSE and around......(read more)

June 13 - Hedge Funds - Comments

Viropharma Inc (VPHM), Actavis Inc (ACT), Akorn, Inc. (AKRX): Can This Experimental Drug Be Brought Back From the Dead?

Five years ago, Viropharma Inc (NASDAQ:VPHM) had everything going for it. Sales of the company’s lead drug, Vancocin — an FDA-approved treatment......(read more)

June 12 - News - Comments

Valeant Pharmaceuticals Intl Inc (VRX) Buys Bausch & Lomb, Boosts The Cooper Companies, Inc. (COO) and Actavis Inc (ACT)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stirred the merger and acquisition space once again with its announcement that it is about to acquire multinational......(read more)

June 10 - News - Comments

Pfizer Inc. (PFE), Actavis Inc (ACT): Which Generic Drugmaker Is Your Best Buy Today?

Generic-drug makers have considerable tailwinds, making their outperformance in the past year unsurprising. However, most companies within this sub-......(read more)

June 6 - News - Comments

Could Warner Chilcott Plc (WCRX) Receive a Higher Bid?

Recently, Actavis Inc (NYSE:ACT) announced that it would acquire Warner Chilcott Plc (NASDAQ:WCRX) for around $8.5 billion in total consideration. Since......(read more)

May 30 - News - Comments

Liberty Media Corp (LMCA), Actavis Inc (ACT), AbbVie Inc (ABBV): Investing Opportunity in 3 Profit Making Companies

Charles Schwab Investment Management is one of the largest asset management companies, having assets worth $217 billion under management as on March 31......(read more)

May 29 - News - Comments

Valeant Pharmaceuticals Intl Inc (VRX), Actavis Inc (ACT): Sticking With a Winning Strategy

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has built a unique, winning drug business by acquiring underperforming niche product franchises and incorporating......(read more)

May 28 - News - Comments

Abbott Laboratories (ABT), Celgene Corporation (CELG) & Three Pharma Companies to Buy in 2013

Currently, a majority of pharma companies are facing the issue of generic competition. This has forced them to either expand their footprints in different......(read more)

May 28 - News - Comments

BHP Billiton Limited (ADR) (BHP), Rio Tinto plc (ADR) (RIO): Five Great Countries for Minimum-Wage Workers

Raising the minimum wage has become a hot-button issue in the U.S. recently, with President Obama having called for a raise in the federal minimum wage......(read more)

May 28 - News - Comments

Warner Chilcott Plc (WCRX), Endo Health Solutions Inc (ENDP): An Undervalued Play in Pharma

Generic pharmaceutical manufacturer Actavis Inc (NYSE:ACT) made headlines after confirming that it has entered into early stage discussions with Ireland......(read more)

May 20 - News - Comments

Warner Chilcott Plc (WCRX) News: Actavis Inc (ACT) Update, £18 Million Gain & More

Editor’s Note: Warner Chilcott Plc (NASDAQ:WCRX), Actavis Inc (NYSE:ACT) Actavis to buy Warner Chilcott in $5 billion stock deal (Reuters) Generic......(read more)

May 20 - News - Comments

Valeant Pharmaceuticals Intl Inc (VRX), Actavis Inc (ACT): How Would A Combined Company Look?

News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE:ACT) emerged......(read more)

May 15 - News - Comments

Is Actavis Inc (ACT) a Buy at This Price?

Actavis Inc (NYSE:ACT), the largest generic drug company in the US, just got even bigger. In a deal valued at $8.5 billion, Actavis Inc (NYSE:ACT) has......(read more)

May 1 - News - Comments

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will The Transition Be Effective?

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting......(read more)

April 23 - News - Comments

Pfizer Inc. (PFE): Could Novartis AG (ADR) (NVS) Decision Bring Pharma Sector Rotation?

One of the best places to be fully invested these days is pharmaceuticals. Over the last year the biggest drug makers, like Pfizer Inc. (NYSE:PFE), Johnson......(read more)

April 2 - News - Comments

Actavis Inc (ACT) Profits Decrease As Acquisition Takes Toll: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan Inc. (MYL)

U.S. generics firm Actavis Inc (NYSE:ACT), previously Watson Pharmaceuticals, reported a strong jump in its revenues in the fourth quarter and total earnings......(read more)

March 17 - News - Comments

Reckitt Benckiser Group Plc (RB): One of the Best Under-the-Radar Investment Catalysts of the Next Year – Actavis Inc (ACT)

One under-the-radar drug recently lost its patent protection and the result could have huge ramifications for the company that tried to fight the onslaught......(read more)

March 15 - News - Comments

Posts Tagged ‘Actavis Inc. (ACT)’